NIH NICEATM Postdoctoral Opportunity for Interactive Visualization and Democratization of Computational Toxicology Tools (MoVIZ+)

About the role

This postdoctoral research opportunity is available within the National Institutes of Health (NIH), National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM). The opportunity focuses on expanding the MoVIZ (Modeling and Visualization) pipeline to create next-generation interactive visualization and decision-support tools for computational toxicology.

Responsibilities

• Learn how to design, prototype, and evaluate interactive scientific visualization tools for large toxicological and chemical datasets using modern web technologies and reproducible development practices.
• Gain experience in human-centered design, explainable AI, prediction uncertainty, applicability domains, and model predictions in decision-support settings.
• Learn how to integrate visualization methods with predictive models, data resources, and scalable workflows within NICE and the MoVIZ ecosystems.
• Additional learning includes interdisciplinary collaboration, scientific writing and communication, user experience-focused development, and dissemination of open-science tools that promote democratize adoption of computational toxicology.

Qualifications

• The candidate must be 18 years or older at the time of application.
• The candidate must have received a doctoral degree in one of the relevant fields within the last five years of the appointment start date.
• Citizenship: U.S. citizens, Lawful Permanent Residents (LPR), and foreign nationals are eligible.

Benefits

• A monthly stipend to help offset living and other expenses during the appointment.
• Health insurance supplement available if the ORAU/ORISE health insurance plan is elected.

Pay

• The stipend rate is determined by NIH officials and is based on the candidate’s academic and professional background.

Schedule

• The appointment will initially be for one year but may be renewed yearly for up to 4 additional years upon recommendation of NIH and is contingent on the availability of funds.